Solana Co — Director's Dealing 2019

Nov 1, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2019-10-29

Reporting Person: LaViscount Joyce N (CFO and COO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-29	Employee Stock Option (Right to Buy)	$1.73	A	150000	Acquired	2029-09-23	Common Stock (150000)	Direct

Footnotes

F1: Represents a stock option to purchase 150,000 shares of the Issuer's common stock (the "Option") granted pursuant to the Issuer's 2018 Omnibus Incentive Plan on September 23, 2019, which shares originally were scheduled to vest upon the achievement of a performance-based vesting milestone. Pursuant to Section 16 of the Securities Exchange Act of 1934, as amended, and the rules thereunder, a grant of stock options subject to performance-based vesting conditions is not reportable on Form 4 until such vesting conditions are satisfied.

F2: Effective October 29, 2019, the Compensation Committee of the Issuer amended the terms of the Option to replace the performance-based vesting schedule with a time-based vesting schedule, whereby 25% of the shares underlying the Option shall vest on September 30, 2020, and the remainder of the shares underlying the Option shall vest in equal monthly installments over the following 48 months, subject to the Reporting Person's continued service through each such date. Upon the establishment of the time-based vesting schedule, the award became reportable on Form 4.